Biocytogen Enters Agreement With CtM Bio to Co-develop TCR-Mimic Antibody-Based Multi-Specific T cell Engagers Read more
Ankyra Therapeutics Announces Cooperative Research and Development Agreement with the National Cancer Institute Read more
Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan Read more
Ocugen, Inc. to Commercialize COVAXIN in Mexico, Rights Now Encompassing All of North America Read more
China NMPA Approves Tislelizumab for Patients with Second-Line Esophageal Squamous Cell Carcinoma Read more
FDA Extends Review of Biologics License Application for REGEN-COV (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19 Read more
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age Read more